FDA Inspection 1171593 — American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.

American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. — FEI 3015417637

The FDA completed an inspection of American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. on Jun 9, 2022 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 9, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.